Research ExplorerPublicationsInteraktionen von Leber und Lunge

Interaktionen von Leber und Lunge

Standard

Interaktionen von Leber und Lunge. / Fuhrmann, V; Tariparast, P.

In: MED KLIN-INTENSIVMED, Vol. 113, No. 6, 09.2018, p. 464-469.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Fuhrmann, V & Tariparast, P 2018, 'Interaktionen von Leber und Lunge', MED KLIN-INTENSIVMED, vol. 113, no. 6, pp. 464-469. https://doi.org/10.1007/s00063-018-0473-3

APA

Fuhrmann, V., & Tariparast, P. (2018). Interaktionen von Leber und Lunge. MED KLIN-INTENSIVMED, 113(6), 464-469. https://doi.org/10.1007/s00063-018-0473-3

Vancouver

Fuhrmann V, Tariparast P. Interaktionen von Leber und Lunge. MED KLIN-INTENSIVMED. 2018 Sep;113(6):464-469. https://doi.org/10.1007/s00063-018-0473-3

Bibtex

@article{57612e0f75cb43fda571f5b62c212ec1,
title = "Interaktionen von Leber und Lunge",
abstract = "Liver-lung interactions are common in daily clinical practice. However, frequently they are not the focus of clinical attention. For example, 10% of patients with acute-on-chronic liver failure and more than 30% of patients with advanced stages of acute-on-chronic liver failure suffer from respiratory failure. Conversely, up to 20% of critically ill patients develop secondary liver failure as a consequence of cardiopulmonary diseases or sepsis during their stay in the intensive care unit. This article provides an overview of clinically relevant liver-lung interactions, consecutively acquired pulmonary and hepatic diseases and the therapeutic implications.",
keywords = "English Abstract, Journal Article, Review",
author = "V Fuhrmann and P Tariparast",
year = "2018",
month = sep,
doi = "10.1007/s00063-018-0473-3",
language = "Deutsch",
volume = "113",
pages = "464--469",
journal = "MED KLIN-INTENSIVMED",
issn = "2193-6218",
publisher = "Springer Medizin",
number = "6",

}

RIS

TY - JOUR

T1 - Interaktionen von Leber und Lunge

AU - Fuhrmann, V

AU - Tariparast, P

PY - 2018/9

Y1 - 2018/9

N2 - Liver-lung interactions are common in daily clinical practice. However, frequently they are not the focus of clinical attention. For example, 10% of patients with acute-on-chronic liver failure and more than 30% of patients with advanced stages of acute-on-chronic liver failure suffer from respiratory failure. Conversely, up to 20% of critically ill patients develop secondary liver failure as a consequence of cardiopulmonary diseases or sepsis during their stay in the intensive care unit. This article provides an overview of clinically relevant liver-lung interactions, consecutively acquired pulmonary and hepatic diseases and the therapeutic implications.

AB - Liver-lung interactions are common in daily clinical practice. However, frequently they are not the focus of clinical attention. For example, 10% of patients with acute-on-chronic liver failure and more than 30% of patients with advanced stages of acute-on-chronic liver failure suffer from respiratory failure. Conversely, up to 20% of critically ill patients develop secondary liver failure as a consequence of cardiopulmonary diseases or sepsis during their stay in the intensive care unit. This article provides an overview of clinically relevant liver-lung interactions, consecutively acquired pulmonary and hepatic diseases and the therapeutic implications.

KW - English Abstract

KW - Journal Article

KW - Review

U2 - 10.1007/s00063-018-0473-3

DO - 10.1007/s00063-018-0473-3

M3 - SCORING: Review

C2 - 30083871

VL - 113

SP - 464

EP - 469

JO - MED KLIN-INTENSIVMED

JF - MED KLIN-INTENSIVMED

SN - 2193-6218

IS - 6

ER -